7th InterAmerican Oncology Conference

“Current Status and Future of Anti-Cancer Targeted Therapies”
5-6 October, 2017

Conference Chairmen

Alex A. Adjei, Buffalo, USA
Román Perez Soler, New York, USA
Josep Tabernero, Barcelona, Spain

Under the Auspices of

Academia Nacional de Medicina
Asociación Colombiana de Hematología y Oncología
Asociación Médica Argentina
European Organisation for Research and Treatment of Cancer
Instituto Nacional del Cáncer
Instituto de Cancerología de México
Sociedad Argentina de Cancerología
Sociedad Argentina de Hematología
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Urología
Sociedad Brasileira de Hematología e Hemoterapia
Sociedad Brasileira de Oncología Clínica
Sociedad Chilena de Cancerología
Sociedad Chilena de Hematología
Sociedad de Medicina Interna de Buenos Aires
Sociedad de Oncología Médica y Pediátrica de Uruguay
Sociedad Peruana de Oncología Médica
Sociedad Venezolana de Hematología
Declared of special scientific interest by European School of Medicine, European Society of Radiotherapy and Oncology, Facultad de Medicina, University of Buenos Aires and Sociedade Brasileira de Cirurgia Oncológica.


Alex A. Adjei, M.D., Ph.D.
Consultant in Oncology
Professor of Oncology
Mayo Clinic
Rochester, Minnesota, USAKenneth C. Anderson, M.D.
Kraft Family Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts, USA

Stephen M. Ansell, M.D., Ph.D.
Professor of Medicine
Chair Lymphoma Group
Mayo Clinic
Rochester, Minnesota, USA

Carlos H. Barrios, M.D.
Director Hospital do Cancer Mãe de Deus
Porto Alegre RS, Brazil

Jorge Cortés, M.D.
Professor of Medicine
Chief, CML & AML Sections
Deputy Chair, Department of Leukemia
M.D. Anderson Cancer Center
Houston, Texas, USA

Bernard Escudier, M.D.
Medical Oncologist
Member of the GU Group
Gustave Roussy
Villejuif, France

Román Pérez-Soler, M.D.
Chairman, Department of Oncology
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, New York, USA

Daniel P. Petrylak, M.D.
Director, Genitourinary Oncology Program
Co Director, Signal Transduction Program
Yale University Cancer Center
New Haven, Connecticut, USA

Gabriel A. Rabinovich, Ph.D.
Head of the Laboratoy of Immunopathology
Instituto de Biología y Medicina Experimental (IBYME)
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)
Member of the USA National Academy of Sciences
Buenos Aires, Argentina

Antoni Ribas, M.D., Ph.D.
Professor of Medicine and Surgery
Professor of Molecular and Medical Pharmacology
Director Tumor Immunology Program, Jonsson
Comprehensive Cancer Center (JCCC)
David Geffen School of Medicine, UCLA
Chair, Melanoma Committee at SWOG
Los Angeles, California, USA

Josep Tabernero, M.D., Ph.D.
Chairman Medical Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain


The supporting companies have no control over the selection of the faculty or the content of the presentations.

AbbVieAstra ZenecaBristol MyersMSD-Ireland-4140





Boehringer Ingelheim


BioMakersDiagnostico Maipumerck_m_detail

Cancer JournalCrystal-horiFundacionAvonJCMT-logoLa-Agenda-Medicascidoc-publishersthe-lancet-oncology